Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/180505
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Blanco Palmero, Víctor Antonio | - |
dc.contributor.author | Rubio Fernández, Marcos | - |
dc.contributor.author | Antequera, Desiree | - |
dc.contributor.author | Villarejo Galende, Alberto | - |
dc.contributor.author | Molina, José Antonio | - |
dc.contributor.author | Ferrer, Isidro | - |
dc.contributor.author | Bartolome, Fernando | - |
dc.contributor.author | Carro, Eva | - |
dc.date.accessioned | 2021-10-11T11:06:48Z | - |
dc.date.available | 2021-10-11T11:06:48Z | - |
dc.date.issued | 2021-08-27 | - |
dc.identifier.issn | 2227-9059 | - |
dc.identifier.uri | http://hdl.handle.net/2445/180505 | - |
dc.description.abstract | Neuroinflammation is a common feature in Alzheimer's (AD) and Parkinson's (PD) disease. In the last few decades, a testable hypothesis was proposed that protein-unfolding events might occur due to neuroinflammatory cascades involving alterations in the crosstalk between glial cells and neurons. Here, we tried to clarify the pattern of two of the most promising biomarkers of neuroinflammation in cerebrospinal fluid (CSF) in AD and PD. This study included cognitively unimpaired elderly patients, patients with mild cognitive impairment, patients with AD dementia, and patients with PD. CSF samples were analyzed for YKL-40 and C-reactive protein (CRP). We found that CSF YKL-40 levels were significantly increased only in dementia stages of AD. Additionally, increased YKL-40 levels were found in the cerebral orbitofrontal cortex from AD patients in agreement with augmented astrogliosis. Our study confirms that these biomarkers of neuroinflammation are differently detected in CSF from AD and PD patients. | - |
dc.format.extent | 14 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI AG | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/biomedicines9091094 | - |
dc.relation.ispartof | Biomedicines, 2021, vol. 9, num. 9, p. 1094 | - |
dc.relation.uri | https://doi.org/10.3390/biomedicines9091094 | - |
dc.rights | cc by (c) Blanco Palmero, Víctor Antonio et al, 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Malaltia d'Alzheimer | - |
dc.subject.classification | Malaltia de Parkinson | - |
dc.subject.classification | Glicoproteïnes | - |
dc.subject.other | Alzheimer's disease | - |
dc.subject.other | Parkinson's disease | - |
dc.subject.other | Glycoproteins | - |
dc.title | Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2021-10-07T08:01:09Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 34572280 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
biomedicines-09-01094.pdf | 1.65 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License